| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $318.9M | $317.0M | $319.0M |
| YoY Revenue Growth % | +0.6% | -0.6% | — |
| Gross Profit | $239.1M | $236.1M | — |
| Gross Margin % | 75.0% | 74.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$39.1M | -$59.3M | -$54.9M |
| Operating Margin % | -12.3% | -18.7% | -17.2% |
| Net Income (GAAP) | -$59.3M | -$81.9M | -$75.6M |
| EBITDA (Normalized) | -$31.1M | -$51.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.9M | -$9.1M | $2.6M |
| Capital Expenditures (CapEx) | $10.0M | $9.4M | — |
| Free Cash Flow (FCF) | -$2.0M | -$18.5M | $2.6M |
| FCF Margin % | -0.6% | -5.8% | 0.8% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $43.0M | $45.3M | — |
| Total Debt (Short + Long Term) | $126.5M | $117.7M | — |
| Total Stockholders' Equity | -$186.1M | -$177.2M | — |